Member Info for CHELSEA7

Buys 1,703,416

Sells 308,187

VWAP 5.44361........................44 Trades..............As Knowlesi said buying was poor, lol.

Same again Monday, have a good weekend all.

A very good day.

16.29 at 5.40

SCANCELL Retweeted

Oxford Science Park
?

@OxfordSciencePK
8h8 hours ago
More Oxford Science Park Retweeted SCANCELL
Clinical trial progress from one of our occupiers!Oxford Science Park added,
SCANCELL

@scancellpharma
New SCIB1 combination trial to start soon in UK https://twitter.com/proactive_UK/status/1121307616859312128 …
0 replies 3 retweets 4 likes
Reply Retweet 3 Like 4

SCANCELL
?

@scancellpharma
8h8 hours ago
More SCANCELL Retweeted Proactive Investors
New SCIB1 combination trial to start soon in UK

INVESTOR UPDATE
Thursday 25th April 2019
with @AndrewScottTV
#stocks #LSE #FTSE100 #AIM #proactive #investors #news #business #finance
http://www.proactiveinvestors.co.uk

https://www.trinitydelta.org/research-notes/phase-ii-melanoma-study-with-scib1-to-start-in-q219/

Dalestar, my thoughts entirely, and presuming we get this right everything we hope for will be achieved.

It does, and i don"t feel it will be too long before the FDA give approval too. Looking back i do think delays have been down to working on tight budgets and not enough personnel and the resources we had were just with Immunobody in mind. That all changed with the discovery of Moditope and with SCIB2 now in CRUKs hands, and SCIB1 ready for trial, all resources are now directed at Moditope/Glycans/TCR with even manufacturing of sample size vaccines now an in house addition. Hopefully we now have enough experience to speed up research and ensure timelines are met better.

With salary increases for key personnel and the addition of two new key members of the team, it would seem odd timing if the BOD had no idea where any funding was coming from? If not funding directly for Immunobody at this stage, I do believe funding for Moditope is known and that and the momentum of having the SCIB 1 trial up and running will i believe allow us to raise in the market at a much higher SP any additional funds we will need to finally remove that elephant from the room. That is what I believe, it makes sense to me, and lets hope we succeed.

GL everybody, at last we are back in trials, with more to come and an inflection based news flow to start catching up with the IP. Let it begin................

Ruck, yeah i saw it, thats why i asked about the new vaccine, they couldn"t have met 2015 timelines and clinically test with Keytruda if the vaccine wasn"t available till 2017.

Never mind, tired, catch yer tomoz.

Ruck, just a quickie, what was your conclusion?

Thanks Ruck, so that would have affected your post about the 2015 announcement especially adding clinical testing with Keytruda to the mix. So taking that into consideration adding the time needed to test with Keytruda the wait has not been as ridiculous as some make it sound.

I am sure we feel cnfident again seeing this target H1 being met, and it gives me every confidence that we will get approval for the U.S arm, unlike the doubts a certain poster is already sewing.

Night guys.

Thanks for that Pro-active link interview with Cliff Holloway..................

https://www.proactiveinvestors.co.uk/companies/stocktube/13102/scancell-to-begin-dosing-in-uk-phase-ii-trial-of-flagship-skin-cancer-drug-13102.html

Very confident sounding CH, so 2 sites in the U.S.A and 3 here in the U.K, Open label, so regular updates, finishing end 2020. Mentions MOD1 which will be in clinic 2020, and as we know first dosing of patients for SCIB1 by end H1 2019. So would be no surprise to join up again with Keith Flaherty for the U.S. arm. Big plans and confidence from a man who has no electricity whilst he is at work, and again i just get a feeling there is a plan for funding and i would hazard a guess being an Open Label trial we will be waiting for first data if funding is an option, along with any plans they might know are in place. That will take us to September.

Yes big news today, not quite on par with having a new auditor (enjoyed the post though) it is a significant moment in our short history and a slow rise from herein is what we want to see, not just the RNS reaction on the day.

Sorry for being lazy, about to sleep. When did we have to re-order the SCIB 1 vaccine??

Thanks so much monkster, best wishes to you too.

I feel the same as you, re the two new staff, i just have a good feeling about future funding, there are still many ways this can go. Can"t agree it is just a fluff, lol and a capital raise is not needed yet. Be very wary of the self congratulatory .................., would Scancell have taken on the new staff knowing they would have to raise at a pittance? I don"t think so. Take care buddy,

Ha ha, that is true. Well lets see what tonight brings, regardless pleased with the RNS today, plenty of news to come with regard to trial plan and at least we are back in trial. We can build from this and attract new shareholders too,

Was up just about all night waiting on that, lol, so hope we have another wave today and you guys will see any video interviews tomorrow before me. Goodnight guys just hoping we can get a regular news flow going now.

Catch yer tomorrow.

Just thinking you have a few good questions to ask Scancell. Have you not thought of e-mailing Cliff Holloway with them. They will answer, and as long as it is not inside info all the clearer. Just a thought.

Agree with that chester, but pretty sure there will be a video interview posted by tomorrow. Disappointed i cannot attend tonight, i really wanted too, and not sure if anybody is.

Happy with this mornings RNS, I am sure many of us feel relieved at hearing that, and plenty more news to come. As yo say though pretty sure too tonights presentation will not be just about SCIB 1 Trial, we might get more news later, might not. But we are back in trials, it has been a long wait, lets hope now so many jigsaw pieces can be put together in the days ahead. But yes it is good news, not for those who want us lower but more focus will be on us again and I just have a really good feeling about the rest of our pipeline.

5,20/5.50

5.30/5.70

now 5,20/5,70

And again 5.40/5.70

+7.77%